Remedium Capital Partners »

Crescent Biopharma shares owned by Remedium Capital Partners

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Remedium Capital Partners from 13F filings

Historical chart of Remedium Capital Partners investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Remedium Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Remedium Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.5M 361k 18.00

More positions owned by Remedium Capital Partners

Oruka Therapeutics (ORKA)
Aeglea Biotherapeutics (SYRE)
Apogee Therapeutics (APGE)
Galecto (DMRA)
Jade Biosciences (JBIO)
Crescent Biopharma (CBIO)

View all positions for Remedium Capital Partners

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Logos Global Management
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
BlackRock
Tang Capital Management
Vanguard Capital Management
Millennium Management
Geode Capital Management
Jennison Associates

View all funds holding Crescent Biopharma